Insider Transactions in Q1 2025 at Optimize Rx Corp (OPRX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 15
2025
|
Doug Besch Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,386
-2.62%
|
$8,316
$6.64 P/Share
|
|
Feb 15
2025
|
Edward Stelmakh CFO/COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,156
-2.22%
|
$12,936
$6.64 P/Share
|
|
Feb 15
2025
|
Marion Odence Ford Chief Legal Officer & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,479
-2.08%
|
$8,874
$6.64 P/Share
|
|
Feb 15
2025
|
Stephen L Silvestro Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,298
-1.88%
|
$13,788
$6.64 P/Share
|
|
Feb 14
2025
|
William J Febbo CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
401
-0.07%
|
$2,406
$6.64 P/Share
|
|
Feb 11
2025
|
Marion Odence Ford Chief Legal Officer & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,386
-1.91%
|
$6,930
$5.6 P/Share
|
|
Feb 11
2025
|
Marion Odence Ford Chief Legal Officer & CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+5.22%
|
-
|
|
Feb 02
2025
|
Cathy Klema Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,109
+30.3%
|
-
|